Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.

Hottinger AF, Ben Aissa A, Espeli V, Squiban D, Dunkel N, Vargas MI, Hundsberger T, Mach N, Schaller K, Weber DC, Bodmer A, Dietrich PY.

Br J Cancer. 2018 Mar 20;118(6):e10. doi: 10.1038/bjc.2017.469. Epub 2018 Jan 9.

2.

Are there clinical variables determining antibiotic prophylaxis-susceptible versus resistant infection in open fractures?

Gonzalez A, Suvà D, Dunkel N, Nicodème JD, Lomessy A, Lauper N, Rohner P, Hoffmeyer P, Uçkay I.

Int Orthop. 2014 Nov;38(11):2323-7. doi: 10.1007/s00264-014-2395-x. Epub 2014 Jun 21.

PMID:
24951947
3.

Control of morphogenesis, protease secretion and gene expression in Candida albicans by the preferred nitrogen source ammonium.

Dunkel N, Biswas K, Hiller E, Fellenberg K, Satheesh SV, Rupp S, Morschhäuser J.

Microbiology. 2014 Aug;160(Pt 8):1599-1608. doi: 10.1099/mic.0.078238-0. Epub 2014 May 19.

PMID:
24841705
4.

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.

Hottinger AF, Ben Aissa A, Espeli V, Squiban D, Dunkel N, Vargas MI, Hundsberger T, Mach N, Schaller K, Weber DC, Bodmer A, Dietrich PY.

Br J Cancer. 2014 May 27;110(11):2655-61. doi: 10.1038/bjc.2014.209. Epub 2014 May 1. Erratum in: Br J Cancer. 2018 Jan 09;:.

5.

Short duration of antibiotic prophylaxis in open fractures does not enhance risk of subsequent infection.

Dunkel N, Pittet D, Tovmirzaeva L, Suvà D, Bernard L, Lew D, Hoffmeyer P, Uçkay I.

Bone Joint J. 2013 Jun;95-B(6):831-7. doi: 10.1302/0301-620X.95B6.30114.

PMID:
23723281
6.

Roles of different peptide transporters in nutrient acquisition in Candida albicans.

Dunkel N, Hertlein T, Franz R, Reuß O, Sasse C, Schäfer T, Ohlsen K, Morschhäuser J.

Eukaryot Cell. 2013 Apr;12(4):520-8. doi: 10.1128/EC.00008-13. Epub 2013 Feb 2.

7.

The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.

Sasse C, Dunkel N, Schäfer T, Schneider S, Dierolf F, Ohlsen K, Morschhäuser J.

Mol Microbiol. 2012 Nov;86(3):539-56. doi: 10.1111/j.1365-2958.2012.08210.x. Epub 2012 Aug 28.

8.

Wound dehiscence and stump infection after lower limb amputation: risk factors and association with antibiotic use.

Dunkel N, Belaieff W, Assal M, Corni V, Karaca Ş, Lacraz A, Uçkay I.

J Orthop Sci. 2012 Sep;17(5):588-94. doi: 10.1007/s00776-012-0245-5. Epub 2012 Jun 6.

PMID:
22669444
9.

Should the methicillin-resistant Staphylococcus aureus carriage status be used as a guide to treatment for skin and soft tissue infections?

Reber A, Moldovan A, Dunkel N, Emonet S, Rohner P, Tahintzi P, Hoffmeyer P, Harbarth S, Uçkay I.

J Infect. 2012 May;64(5):513-9. doi: 10.1016/j.jinf.2011.12.023. Epub 2012 Feb 1.

PMID:
22327191
10.

Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies.

Kowalczyk C, Dunkel N, Willen L, Casal ML, Mauldin EA, Gaide O, Tardivel A, Badic G, Etter AL, Favre M, Jefferson DM, Headon DJ, Demotz S, Schneider P.

J Biol Chem. 2011 Sep 2;286(35):30769-79. doi: 10.1074/jbc.M111.267997. Epub 2011 Jul 5.

11.

Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.

Schubert S, Barker KS, Znaidi S, Schneider S, Dierolf F, Dunkel N, Aïd M, Boucher G, Rogers PD, Raymond M, Morschhäuser J.

Antimicrob Agents Chemother. 2011 May;55(5):2212-23. doi: 10.1128/AAC.01343-10. Epub 2011 Mar 14.

12.

Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience.

Rod-Fleury T, Dunkel N, Assal M, Rohner P, Tahintzi P, Bernard L, Hoffmeyer P, Lew D, Uçkay I.

Int Orthop. 2011 Nov;35(11):1725-31. doi: 10.1007/s00264-011-1221-y. Epub 2011 Feb 12.

13.

Role of the Npr1 kinase in ammonium transport and signaling by the ammonium permease Mep2 in Candida albicans.

Neuhäuser B, Dunkel N, Satheesh SV, Morschhäuser J.

Eukaryot Cell. 2011 Mar;10(3):332-42. doi: 10.1128/EC.00293-10. Epub 2011 Jan 28.

14.

Loss of heterozygosity at an unlinked genomic locus is responsible for the phenotype of a Candida albicans sap4Δ sap5Δ sap6Δ mutant.

Dunkel N, Morschhäuser J.

Eukaryot Cell. 2011 Jan;10(1):54-62. doi: 10.1128/EC.00281-10. Epub 2010 Nov 19.

15.

Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.

Dunkel N, Blass J, Rogers PD, Morschhäuser J.

Mol Microbiol. 2008 Aug;69(4):827-40. doi: 10.1111/j.1365-2958.2008.06309.x. Epub 2008 May 27.

16.

A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.

Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD.

Eukaryot Cell. 2008 Jul;7(7):1180-90. doi: 10.1128/EC.00103-08. Epub 2008 May 16.

Supplemental Content

Loading ...
Support Center